본 보고서에서는 제약 업계의 라이선스 계약 동향을 조사하고, 기업들이 라이선스 계약을 체결하는 방법과 이유에 대한 자세한 이해와 분석을 제공합니다.
전면 개정 및 업데이트된 본 보고서는 2019년부터 2025년까지의 라이선스 계약에 대한 세부 정보를 제공합니다.
이 보고서에서는 당사자 간에 발표된 라이선스 계약의 지불 조건에 접근할 수 있습니다. 이 데이터는 지불 조건 및 기타 계약 조건에 대한 유용한 인사이트를 제공합니다.
주요 장점:
본 보고서는 독자들에게 다음과 같은 주요 이점을 제공합니다:
- 2019년 이후 계약 동향을 파악할 수 있습니다.
- 라이선싱 안건을 열람할 수 있습니다.
- 벤치마크 분석 : 거래의 시장 가치를 파악할 수 있습니다.
- 금융 조건 : 일시금, 마일스톤, 로열티를 확인할 수 있습니다.
- 기업(A-Z), 치료 영역, 기술 유형별 계약 디렉토리를 확인할 수 있습니다.
- 주요 거래금액을 확인할 수 있습니다.
- 가장 활발한 딜 메이커를 확인할 수 있습니다.
- 각 약관의 자산과 거래 조건을 확인할 수 있습니다.
- 계약 문서에 대한 액세스 : 계약 구조에 대한 인사이트를 얻을 수 있습니다.
- 실사 : 제안된 계약 조건이 파트너사에 적합한지 평가할 수 있습니다.
- 수백 시간의 조사 시간을 절약할 수 있습니다
조사 범위
- 바이오의약품 업계 라이선스 계약 동향
- 라이선스 계약 구조 개요
- 의약품 및 바이오테크놀러지을 포괄하는 라이선스 계약 기록의 디렉토리
- 주요 라이선스 계약 금액 기준
- 가장 활발한 라이선스 거래 업체
- 주요 라이선스 제휴 리소스
목차
주요 요약
제1장 소개
제2장 라이선스 계약 동향
- 라이선스 계약의 정의
- 2019년 이후 라이선스 계약 동향
- 라이선스 계약 동향 : 연도별
- 라이선스 계약 : 개발 단계별
- 라이선스 계약 : 산업 부문별
- 라이선스 계약 : 치료 분야별
- 라이선스 계약 : 기술 유형별
- 라이선스 계약 : 가장 활발한 기업
- 라이선스 계약을 체결하는 이유
- 라이선스 계약의 미래
제3장 라이선스 계약 구조 : 개요
제4장 주요 라이선스 계약
제5장 가장 활발한 라이선스 계약 업자 상위 25개사
- 가장 활발한 라이선스 계약 업자 상위 25개사
제6장 계약 디렉토리를 포함한 라이선스 계약
- 2019-2025년 계약을 수반하는 라이선스 계약
- 계약 디렉토리
- 계약 디렉토리 라이선스 계약 : 기업별(A-Z)
- 계약 디렉토리 라이선스 계약 : 치료 분야별
- 계약 디레크트리라이센스라이 계약 : 기술 유형별
- Biopharma Research에 대해
- 현재 제휴
- 현재 합의
- Current Partnering에서의 최근 보고서 제목
ksm
Licensing Deals in Pharmaceuticals provides a detailed understanding and analysis of how and why companies enter licensing deals.
Fully revised and updated, the report provides details of licensing deals from 2019 to 2025.
The report provides access to licensing deal payment terms as announced between the parties. This data provides useful insight into the payment and other deal terms.
Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered and rights transferred - contract documents provide this insight where press releases and databases do not.
This report contains a comprehensive listing of licensing deals announced since 2019 as recorded in the Current Agreements deals and alliances database, including financial terms where available, plus links to online copies of actual licensing contract documents as submitted to the Securities Exchange Commission by companies and their partners.
The initial chapters of this report provide an orientation of licensing dealmaking and business activities.
Chapter 1 provides an introduction to the report, whilst chapter 2 provides an overview and analysis of the trends in licensing as well as a discussion on the merits of the type of deal.
Chapter 3 provides an overview of the structure of licensing deals.
Chapter 4 provides a review of the leading licensing deals since 2019. Deals are listed by headline value. Where the deal has an agreement contract published at the SEC a link provides online access to the contract via the Current Agreements deals and alliances database.
Chapter 5 provides a comprehensive listing of the top 25 most active licensing dealmaker companies. Each deal title links via Current Agreements deals and alliances database to an online version of the full deal record, and where available, the actual contract document, providing easy access to each deal record on demand.
Chapter 6 provides a comprehensive and detailed review of licensing deals organized by company A-Z, therapy, technology and industry type signed and announced since 2019 where a contract document is available. Contract documents provide an indepth insight into the actual deal terms agreed between the parties with respect to the licensing deal.
The deal directory includes a comprehensive listing of all licensing deals announced since 2019. Each listing is organized as a deal directory by company A-Z, therapeutic area and technology type. Each deal title links via hyperlink to an online version of the deal record including, where available, the actual contract document.
The report also includes numerous table and figures that illustrate the trends and activities in licensing dealmaking since 2019.
In conclusion, this report provides everything a prospective dealmaker needs to know about licensing alliances.
Key benefits
Licensing Deals in Pharmaceuticals provides the reader with the following key benefits:
- Understand deal trends since 2019
- Browse licensing deals
- Benchmark analysis - identify market value of transactions
- Financials terms - upfront, milestone, royalties
- Directory of deals by company A-Z, therapy focus and technology type
- Leading deals by value
- Most active dealmakers
- Identify assets and deal terms for each transaction
- Access contract documents - insights into deal structures
- Due diligence - assess suitability of your proposed deal terms for partner companies
- Save hundreds of hours of research time
Report scope
- Licensing Deals in Pharmaceuticals is intended to provide the reader with an in-depth understanding of the licensing trends and structure of deals entered into by leading biopharma companies worldwide.
Licensing Deals in Pharmaceuticals includes:
- Trends in licensing dealmaking in the biopharma industry
- Overview of licensing deal structure
- Directory of licensing deal records covering pharmaceutical and biotechnology
- The leading licensing deals by value
- Most active licensing dealmakers
- The leading licensing partnering resources
In Licensing Deals in Pharmaceuticals, the available deals are listed by:
- Company A-Z
- Headline value
- Therapeutic area
- Technology type
- Each deal title links via Weblink to an online version of the actual deal record, providing easy access to each contract document where available.
- Licensing Deals in Pharmaceuticals provides comprehensive access to available records for licensing deals, including contract documents where available.
Analyzing contract agreements allows due diligence of:
- What are the rights granted or optioned?
- What rights are granted by the agreement?
- What exclusivity is granted?
- What is the payment structure for the deal?
- How are sales and payments audited?
- What is the deal term?
- How are the key terms of the agreement defined?
- How are intellectual property rights handled and owned?
- Who is responsible for commercialization?
- Who is responsible for development, supply, and manufacture?
- How is confidentiality and publication managed?
- How are disputes resolved?
- Under what conditions can the deal be terminated?
- What happens when there is a change of ownership?
- What sublicensing and subcontracting provisions have been agreed?
- Which boilerplate clauses does the company insist upon?
- Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
- Which jurisdiction does the company insist upon for agreement law?
Table of Contents
Executive Summary
Chapter 1 - Introduction
Chapter 2 - Trends in licensing dealmaking
- 2.1. Introduction
- 2.2. Definition of licensing deal
- 2.3. Trends in licensing deals since 2019
- 2.3.1. Licensing dealmaking by year, 2019-2025
- 2.3.2. Licensing dealmaking by phase of development, 2019-2025
- 2.3.3. Licensing dealmaking by industry sector, 2019-2025
- 2.3.4. Licensing dealmaking by therapy area, 2019-2025
- 2.3.5. Licensing dealmaking by technology type, 2019-2025
- 2.3.6. Licensing dealmaking by most active company, 2019-2025
- 2.4. Reasons for entering into licensing partnering deals
- 2.5. The future of licensing deals
Chapter 3 - Overview of licensing deal structure
- 3.1. Introduction
- 3.2. Licensing agreement structure
Chapter 4 - Leading licensing deals
- 4.1. Introduction
- 4.2. Top licensing deals by value
Chapter 5 - Top 25 most active licensing dealmakers
- 5.1. Introduction
- 5.2. Top 25 most active licensing dealmakers
Chapter 6 - Licensing deals including contracts directory
- 6.1. Introduction
- 6.2. Licensing deals with contracts 2019-2025
- Deal directory
- Deal directory - licensing dealmaking by companies A-Z
- Deal directory - licensing dealmaking by therapy area
- Deal directory - licensing dealmaking by technology type
- About Biopharma Research
- Current Partnering
- Current Agreements
- Recent report titles from Current Partnering
TABLE OF FIGURES
- Figure 1: Definition of licensing
- Figure 2: Trends in licensing deal announcements, 2019-2025
- Figure 3: Licensing deals signed at each phase of development, 2019-2025
- Figure 4: Licensing deals by industry sector, 2019-2025
- Figure 5: Licensing deals by therapy area, 2019-2025
- Figure 6: Licensing deals by technology type, 2019-2025
- Figure 7: Top 25 most active licensing dealmakers, 2019-2025
- Figure 8: Top licensing deals by value, 2019-2025
- Figure 9: Most active licensing dealmakers, 2019-2025
